A Preliminary Study of microRNA-208b after Acute Myocardial Infarction: Impact on 6-Month Survival.

Mostafa Alavi-MoghaddamMohammad ChehraziShamila D AlipoorMaryam MohammadiAlireza BaratlooMohammad Parsa MahjoubMehrnaz MovasaghiJohan GarssenIssssswan M Adcock Esmaeil Mortaz

Published in: Disease markers (2018)

Our results showed that elevated miR-208b expression was associated with reduced long-term survival in AMI patients. These pilot data indicate the need for a large follow-up study to confirm whether miR-208b can be used as a predictor of 6-month survival time after AMI.

Keyphrases

acute myocardial infarction
end stage renal disease
percutaneous coronary intervention
ejection fraction
newly diagnosed
poor prognosis
left ventricular
prognostic factors
heart failure
electronic health record
clinical trial
study protocol
patient reported outcomes
double blind